Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived.

Name: Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived.
Author: Boughton, B J

Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived. — المؤلف: Boughton, B J — Cancer immunology, immunot

المؤلف: Boughton, B J
النشر: Cancer immunology, immunotherapy : CII 19950920
الوصف: 68-70 p.
الموضوعات: Bone Marrow Transplantation؛ Genetic Markers؛ Graft vs Host Disease؛ Humans؛ Immunotherapy؛ Interleukin-2؛ Killer Cells, Lymphokine-Activated؛ Leukemia, Myeloid, Acute